跳至主要内容
临床试验/NCT04343404
NCT04343404已完成不适用

STUDY ECMO-COVID-19 : Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19

University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Retrospective description of COVID-19 patients receiving respiratory ECMO-VV supplementation and what happens to them

研究概览

简要总结

Describe COVID-19 patients who are receiving ECMO-VV respiratory replacement and what happens to them.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient over the age of 18;
  • Diagnostic COVID-19 by RT-PCR;
  • Hospitalisation in resuscitation for the management of complications related to COVID-19
  • Implanted ECMO-VV during hospitalisation;
  • Patient agreeing to participate in the study

排除标准

  • Sujet under guardianship or trusteeship
  • Sujet under safeguard of justice

结局指标

主要结局

Retrospective description of COVID-19 patients receiving respiratory ECMO-VV supplementation and what happens to them

时间窗: Files analysed retrospectily from March 1st, 2020 to April 15, 2020 will be examined

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Place of ECMO in the Management of Severe Refractory... | 临床试验